Cargando…
Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum
Context: Cholinesterase (ChE) specific activity is the ratio of ChE activity to ChE mass and, as a biomarker of exposure to cholinesterase inhibitors, has a potential advantage over simple ChE activity. Objective: To examine the association of several potential correlates (serum arylesterase/paraoxo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945546/ https://www.ncbi.nlm.nih.gov/pubmed/24473115 http://dx.doi.org/10.3390/ijerph110201422 |
_version_ | 1782306537607266304 |
---|---|
author | Aoki, Yutaka Helzlsouer, Kathy J. Strickland, Paul T. |
author_facet | Aoki, Yutaka Helzlsouer, Kathy J. Strickland, Paul T. |
author_sort | Aoki, Yutaka |
collection | PubMed |
description | Context: Cholinesterase (ChE) specific activity is the ratio of ChE activity to ChE mass and, as a biomarker of exposure to cholinesterase inhibitors, has a potential advantage over simple ChE activity. Objective: To examine the association of several potential correlates (serum arylesterase/paraoxonase activity, serum albumin, sex, age, month of blood collection, and smoking) with plasma ChE specific activity. Methods: We analyzed data from 195 cancer-free controls from a nested case-control study, accounting for potential confounding. Results: Arylesterase activity had an independent, statistically significant positive association with ChE specific activity, and its magnitude was the greatest for the arylesterase phenotype corresponding to the QQ PON1(192) genotype followed by phenotypes corresponding to QR and RR genotypes. Serum albumin was positively associated with ChE specific activity. Conclusions: Plasma arylesterase activity was positively associated with plasma ChE specific activity. This observation is consistent with protection conferred by a metabolic phenotype resulting in reduced internal dose. |
format | Online Article Text |
id | pubmed-3945546 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-39455462014-03-10 Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum Aoki, Yutaka Helzlsouer, Kathy J. Strickland, Paul T. Int J Environ Res Public Health Context: Cholinesterase (ChE) specific activity is the ratio of ChE activity to ChE mass and, as a biomarker of exposure to cholinesterase inhibitors, has a potential advantage over simple ChE activity. Objective: To examine the association of several potential correlates (serum arylesterase/paraoxonase activity, serum albumin, sex, age, month of blood collection, and smoking) with plasma ChE specific activity. Methods: We analyzed data from 195 cancer-free controls from a nested case-control study, accounting for potential confounding. Results: Arylesterase activity had an independent, statistically significant positive association with ChE specific activity, and its magnitude was the greatest for the arylesterase phenotype corresponding to the QQ PON1(192) genotype followed by phenotypes corresponding to QR and RR genotypes. Serum albumin was positively associated with ChE specific activity. Conclusions: Plasma arylesterase activity was positively associated with plasma ChE specific activity. This observation is consistent with protection conferred by a metabolic phenotype resulting in reduced internal dose. MDPI 2014-01-27 2014-02 /pmc/articles/PMC3945546/ /pubmed/24473115 http://dx.doi.org/10.3390/ijerph110201422 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Aoki, Yutaka Helzlsouer, Kathy J. Strickland, Paul T. Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum |
title | Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum |
title_full | Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum |
title_fullStr | Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum |
title_full_unstemmed | Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum |
title_short | Arylesterase Phenotype-Specific Positive Association Between Arylesterase Activity and Cholinesterase Specific Activity in Human Serum |
title_sort | arylesterase phenotype-specific positive association between arylesterase activity and cholinesterase specific activity in human serum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945546/ https://www.ncbi.nlm.nih.gov/pubmed/24473115 http://dx.doi.org/10.3390/ijerph110201422 |
work_keys_str_mv | AT aokiyutaka arylesterasephenotypespecificpositiveassociationbetweenarylesteraseactivityandcholinesterasespecificactivityinhumanserum AT helzlsouerkathyj arylesterasephenotypespecificpositiveassociationbetweenarylesteraseactivityandcholinesterasespecificactivityinhumanserum AT stricklandpault arylesterasephenotypespecificpositiveassociationbetweenarylesteraseactivityandcholinesterasespecificactivityinhumanserum |